Other and unspecified cirrhosis of liver Clinical Trials

27 clinical trials for Other and unspecified cirrhosis of liver across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Molecular Fingerprinting in Cancer Detection — RECRUITING
LIMITS longitudinal study: impact of malnutrition, sarcopenia, and a TIPS insertion on prognosis in liver cirrhosis — RECRUITING
Multimodal analysis of the interactions between hepatocellular carcinoma (HCC), HCC treatment, muscle status, and nutritional status, as well as their relationship to quality of life — RECRUITING
Evaluation of PV-1 as a marker of intestinal permeability in patients with liver cirrhosis — RECRUITING
Influence of the transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients on sarcopenia — RECRUITING
Liver perfusion measurement using PCD-CT to characterize and evaluate the response to treatment of hepatocellular carcinomas of the liver as part of routine CT diagnostics and comparison with MRI liver diagnostics — RECRUITING
Risk of spontaneous bacterial peritonitis after colonoscopy in hydrop decompensated liver cirrhosis — RECRUITING
SEAL - Structured Early Assessment of Asymptomatic Liver Fibrosis and Cirrhosis — RECRUITING
LiverTracer „Device for identification of liver dysfunction“ — RECRUITING
Influence of a TIPS on the intestinal microbial composition in patients with liver cirrhosis — RECRUITING
Multispectral Optoacoustic Tomography (MSOT) for the evaluation of liver fibrosis, steatosis and inflammation — RECRUITING
Clinical course of liver cirrhosis and liver cirrhosis complications — RECRUITING
Macrophage therapy for liver cirrhosis — ACTIVE_NOT_RECRUITING · PHASE1_PHASE2
Prospective, multicentric observational study on the application of ASEPT® and on results from patient surveys in palliative care — OTHER
A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation — OTHER
Usability of a 29mRNA neuronal network for the prediction of infections in patients following liver transplantation — OTHER
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis — OTHER
Multi-center, controlled cross-sectional analysis of the phenotype of malnutrition in patients with liver cirrhosis, chronic pancreatitis and short bowel Syndrome (as part of the Joint project “Enteral nutrition in Malnutrition due to diseases of the gastrointestinal tract: from basic understanding to an innovative treatment concept" (EnErGie)) — OTHER
Remote Ischemic Preconditioning (RIPC) versus sham-control for reduction of ischemia-reperfusion injury of the Liver after liver surgery in patients with pre-damaged liver: a prospective, randomized controlled, triple-blind, clinical phase III monocenter trial — OTHER
Investigation of enzymatic liver funtion in Fontan-palliated patients — OTHER
Mycotic findings in patients after liver transplantation – Invasive mycosis or harmless colonization? — OTHER
Early detection of Fontan-associated liver disease — OTHER
AFP – L3% and DCP as screening marker for a hepatocellular carcinoma in patients with cirrhosis of the liver — OTHER
Incidence and risk factors of viral infections in patients after liver transplantation — OTHER
Analysis of the transsectoral nutritional care of malnourished patients with liver cirrhosis over 6 months (as part of the Joint project “Enteral nutrition in Malnutrition due to diseases of the gastrointestinal tract: from basic understanding to an innovative treatment concept” (EnErGie)) — OTHER
Post-LTPL Organ Dysfunction - Non-invasive diagnostic with aid of plasmatic apoptosis markers — OTHER
Double-Blind, Randomised, Cross-Over, Placebo-Controlled, Single-Centre Phase IIa Clinical Study on the Influence of Udenafil on the Portal Flow in Cirrhotic Patients with Portal Hypertension — OTHER

Refine this search